Bleeding Risk: Using DAPT Score to Minimize Complications While Maintaining Efficacy
Christopher Cannon, Editor in Chief, Harvard Health Publishing, shared a post on LinkedIn:
“A prospective randomized trial using the DAPT Risk score to tailor duration of DAPT – showing benefit in reducing bleeding and overall net benefit!!! I have been using the DAPT Risk score developed by Robert Yeh and Laura Mauri, but this is the first validation.
In the personalized DAPT duration arm, DAPT duration was 3 months for patients with low DAPT score and chronic coronary syndrome, 6 months for patients with low DAPT score and acute coronary syndrome, or 24 months for patients with high DAPT score (irrespective of the clinical presentation).
In the control arm, DAPT duration was 12 months”
Read full article here.
Title: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation
Authors: Raffaele Piccolo, Paolo Calabrò, Greta Carrara, Fiorenzo Simonetti, Attilio Varricchio, Tiziana Attisano, Giovanni Napolitano, Ciro De Simone, Gerardo Carpinella, Eugenio Stabile, Plinio Cirillo, Luigi Di Serafino, Gianluca Caiazzo, Tullio Tesorio, Marco Boccalatte, Bernardino Tuccillo, Marisa Avvedimento, Attilio Leone, Gennaro Galasso, Arturo Cesaro, Rocco Perrotta, Tullio Niglio, Domenico Simone Castiello, Maddalena Immobile Molaro, Luca Bardi, Alessandra Spinelli, Stefano Cristiano, Michele Bellino, Sergio Leonardi, Simone Biscaglia, Francesco Costa, Salvatore Cassese, Eugene McFadden, Dik Heg, Giulio G. Stefanini, Anna Franzone, Davide Capodanno, Giovanni Esposito
Stay updated with Hemostasis Today.
-
Oct 2, 2026, 18:34Kamini Khillan: Massive Transfusion Protocol for PPH Management
-
Oct 2, 2026, 18:24Garima Sharma։ GLP-1 Receptor Agonists Across the Reproductive Life Course
-
Oct 2, 2026, 18:13Priya Sriskandarajah: Roginolisib Plus JAK Inhibitors in Myelofibrosis
-
Oct 2, 2026, 17:40Chokri Ben Lamine: A Two-Day Journey Through Modern Hematology at KFSHRC
-
Oct 2, 2026, 17:27Reza Shojaei: The Invisible Crisis, Part 1- Donor Deferral in Whole Blood
-
Oct 2, 2026, 16:02Advancing Antithrombotic Stewardship to Optimise Care – American Heart Association
-
Oct 2, 2026, 15:37Pall T. Onundarson: Monitoring Warfarin Beyond Factor VII
-
Oct 2, 2026, 15:26Nicola Carter: World Thrombosis Day Highlights Gender Specific Risks and Prevention
-
Oct 2, 2026, 14:56Wolfgang Miesbach: Direct Comparison Reveals Distinct Mechanisms Among FVIIIa Mimetics